VBIV

VBI Vaccines, Inc.

0.58 USD
+0.00 (+0.81%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

VBI Vaccines, Inc. stock is down -16.47% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 March’s closed higher than February.

About VBI Vaccines, Inc.

VBI Vaccines Inc. develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for chronic HBV infection.